ATE203679T1 - Verfahren zur inaktivierung von viralen, parasitären und bakteriellen blutverunreinigungen - Google Patents

Verfahren zur inaktivierung von viralen, parasitären und bakteriellen blutverunreinigungen

Info

Publication number
ATE203679T1
ATE203679T1 AT93903538T AT93903538T ATE203679T1 AT E203679 T1 ATE203679 T1 AT E203679T1 AT 93903538 T AT93903538 T AT 93903538T AT 93903538 T AT93903538 T AT 93903538T AT E203679 T1 ATE203679 T1 AT E203679T1
Authority
AT
Austria
Prior art keywords
viral
inactivation
parasitic
bacterial blood
blood contaminants
Prior art date
Application number
AT93903538T
Other languages
English (en)
Inventor
Raymond P Goodrich Jr
Nagendar Yerram
Roger W Hackett
Marjan Van Borssum Waalkes
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Application granted granted Critical
Publication of ATE203679T1 publication Critical patent/ATE203679T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT93903538T 1992-01-27 1993-01-27 Verfahren zur inaktivierung von viralen, parasitären und bakteriellen blutverunreinigungen ATE203679T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82569192A 1992-01-27 1992-01-27
PCT/US1993/000401 WO1993014791A2 (en) 1992-01-27 1993-01-27 Method of inactivation of viral and bacterial blood contaminants

Publications (1)

Publication Number Publication Date
ATE203679T1 true ATE203679T1 (de) 2001-08-15

Family

ID=25244689

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93903538T ATE203679T1 (de) 1992-01-27 1993-01-27 Verfahren zur inaktivierung von viralen, parasitären und bakteriellen blutverunreinigungen

Country Status (10)

Country Link
EP (1) EP0633786B1 (de)
JP (1) JP2001509773A (de)
AT (1) ATE203679T1 (de)
AU (1) AU3476593A (de)
CA (1) CA2128866A1 (de)
DE (1) DE69330514T2 (de)
IL (1) IL104530A0 (de)
NO (1) NO942781L (de)
WO (1) WO1993014791A2 (de)
ZA (1) ZA93587B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077659A (en) * 1990-05-15 2000-06-20 New York Blood Center, Inc. Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light
US5578486A (en) * 1994-08-05 1996-11-26 International Tlb Research Institute, Inc. Recombinant microbial fertilizer and methods for its production
AU691672B2 (en) * 1994-09-22 1998-05-21 Baxter International Inc. Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers
WO1996036704A1 (en) * 1995-05-19 1996-11-21 New York Blood Center, Inc. Methods of use of phthalocyanines to inactivate blood borne parasites
AU710242B2 (en) * 1996-03-29 1999-09-16 Therakos, Inc. Photopheresis treatment of leukocytes
WO1997037536A1 (en) 1996-04-09 1997-10-16 Therakos, Inc. Method for removal of psoralens from biological fluids
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
DE59800935D1 (en) 1997-04-08 2001-08-02 Baxter Ag Immuntolerante prothrombinkomplex-präparation
WO1999002215A1 (en) * 1997-07-10 1999-01-21 Therakos, Inc. Treatment of inflammatory disorders of the bowel and urinary bladder
CN1203900C (zh) * 1998-01-06 2005-06-01 塞鲁斯公司 用于淬灭生物材料中病原体灭活剂的方法
US7049140B1 (en) 1999-04-29 2006-05-23 Vanderbilt University X-ray guided drug delivery
US6159443A (en) * 1999-04-29 2000-12-12 Vanderbilt University X-ray guided drug delivery
US6219584B1 (en) 1999-07-09 2001-04-17 Therakos, Inc. Method and system for determining an effective amount of light energy to delivery to fluids having targets for the light energy
US6495366B1 (en) 1999-09-03 2002-12-17 Therakos, Inc. Uninterrupted flow pump apparatus and method
US7306925B2 (en) 2001-11-09 2007-12-11 Vanderbilt University Phage antibodies to radiation-inducible neoantigens
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
WO2013019730A1 (en) 2011-07-29 2013-02-07 The Washington University Antibodies to tip-1 and grp78
WO2014194931A1 (en) 2013-06-03 2014-12-11 Onderzoeks- En Ontwikkelingsfonds Rode Kruis-Vlaanderen Pathogen reduction treatment
EP3172222A4 (de) 2014-07-24 2018-03-21 Washington University Gegen strahlungsinduzierte moleküle gerichtete zusammensetzungen und verfahren zur verwendung davon
WO2018148595A1 (en) 2017-02-10 2018-08-16 Washington University Antibodies to tip1 and methods of use thereof
WO2021074970A1 (ja) * 2019-10-15 2021-04-22 株式会社日立ハイテク 核酸試料処理装置および核酸試料処理方法
IL309030A (en) * 2021-06-14 2024-02-01 St Andrews Pharmaceutical Tech Ltd Apparatus for improving hydration and / or reducing particle size of a product and a method of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305390A (en) * 1975-11-28 1981-12-15 Massachusetts Institute Of Technology Method for generating oxygen in an excited electronic state and inactivation of microorganisms
SU959786A1 (ru) * 1980-04-17 1982-09-23 Московский технологический институт мясной и молочной промышленности Способ консервировани цельной крови
US4684521A (en) * 1982-12-08 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
EP0124363B1 (de) * 1983-05-02 1990-12-19 Diamond Scientific Co. Photochemische Entkeimungsbehandlung von vollem Blut oder Blutbestandteilen
JPS61275228A (ja) * 1985-03-14 1986-12-05 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド 治療用タンパク組成物中のビ−ルスの光動的不活性化
AU653337B2 (en) * 1990-04-16 1994-09-29 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US5120649A (en) * 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
EP0544895B1 (de) * 1991-06-21 1997-08-27 Baxter International Inc. Verfahren zur inaktivierung von pathogenen in einer körperflüssigkeit

Also Published As

Publication number Publication date
DE69330514D1 (de) 2001-09-06
JP2001509773A (ja) 2001-07-24
IL104530A0 (en) 1993-05-13
EP0633786A4 (de) 1995-04-19
EP0633786A1 (de) 1995-01-18
WO1993014791A3 (en) 2000-02-17
ZA93587B (en) 1994-07-07
NO942781L (no) 1994-09-15
DE69330514T2 (de) 2002-03-28
CA2128866A1 (en) 1993-08-05
AU3476593A (en) 1993-09-01
EP0633786B1 (de) 2001-08-01
WO1993014791A2 (en) 1993-08-05
NO942781D0 (no) 1994-07-26

Similar Documents

Publication Publication Date Title
ATE203679T1 (de) Verfahren zur inaktivierung von viralen, parasitären und bakteriellen blutverunreinigungen
ATE232737T1 (de) Methode zur unschädlichmachung viraler und bakterieller blutverunreinigungen
DK0653911T3 (da) Fremgangsmåder til inaktivering af bakterier i blodpræparater med 8-methoxypsoralen
GB8807380D0 (en) Blood processing apparatus
ATE194921T1 (de) Verfahren zur inaktivierung von viren
DE69201235D1 (de) Behälter zur bestrahlung von blutprodukten.
ATE138575T1 (de) Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen
DE69432832D1 (de) Vorrichtung und verfahren zur photoaktivierung
DE3680322D1 (de) Antibioticahaltiges mittel und seine verwendung als chirurgisches kunststoffmaterial.
DE3789158D1 (de) Verfahren zur Sterilisation und Vorrichtung dafür.
KR960703625A (ko) 제품의 살균방법(method for sterilizing products)
ATE301186T1 (de) Verfahren zur sterilisation biologischer zusammensetzungen und das dabei erhaltene produkt
ATE316039T1 (de) Verfahren zur sterilisation von geschlossenen behältern
DE69530761D1 (de) Methode und poröser träger zur entfernung von verunreinigungen
CA2056619A1 (en) Method of inactivation of viral and bacterial blood contaminants
ATE115863T1 (de) Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen.
DE59106064D1 (de) Verfahren und Vorrichtung zur biologischen Reinigung von verunreinigten Böden.
ATE70181T1 (de) Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie.
DE58903378D1 (de) Traegergebundenes mehrkomponentiges nachweissystem zur kolorimetrischen bestimmung esterolytisch oder/und proteolytisch aktiver inhaltsstoffe von koerperfluessigkeiten.
DE59107602D1 (de) Verfahren und Mittel zur Beseitigung von Trübungen in biologischen Flüssigkeiten
DE3777022D1 (de) Verfahren und praeparat zur inaktivierung von viren.
ATE125713T1 (de) Verfahren zur inaktivierung der biologischen aktivität von dna.
EP0330647A3 (en) The use of chymotrypsin for the inactivation of prekallikrein activator
KR900018367A (ko) 마이코플라즈마를 함유한 세포배양물의 오염제거 방법
ATE96039T1 (de) Arzneimittel und ihre verwendung zur behandlung von parasitosen.